Article
SRD5A3-CDG: A Patient with a Novel Variant and Brain Neoplasm.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP - 1 Dec 2022
Kasapkara Cigdem Seher, Olgac Asburce, Derinkuyu Betul Emine, Oztoprak Ulkuhan, Jaeken Jaak
Abstract excerpt
Congenital disorders of glycosylation (CDGs) are a large group of genetic diseases with impaired glycosylation of glycoproteins and glycolipids, and glycosylphosphatidylinositol anchor synthesis. Steroid 5α-reductase 3 (SRD5A3)-CDG is a CDG type I with a clinical spectrum of neurological, ophthalmological, dermatological and hepatic symptoms. Although CDGs are not directly related to malignancies, it is well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
